FindTrial
Sign In

EQ-5D-5L

OTHER3 trials

Sponsors

Belfast Health & Social Care Trust (UK), Afyonkarahisar Health Sciences University, Karolinska Institutet

Conditions

Ankylosing SpondylitisArthroplasty ComplicationsDiabetic macular oedema (DMO) Eye Diseases Diabetic macular oedema (DMO)Inflammatory Joint Disease (IJD)PolyarthritisPsoriatic ArthritisRheumatoid Arthritis (RA)

Phase 2

Use of ARA 290 for the treatment of diabetic macular oedema
Active, not recruitingISRCTN16962255
Belfast Health & Social Care Trust (UK)Diabetic macular oedema (DMO) Eye Diseases Diabetic macular oedema (DMO)
Start: 2015-09-01Target: 10Updated: 2024-07-15

Unknown Phase

Validity and Reliability of High-Activity Arthroplasty Score
NCT05211310
Afyonkarahisar Health Sciences UniversityArthroplasty Complications
Start: 2022-05-01End: 2025-12-01Target: 70Updated: 2023-12-27
Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint Disease
CompletedNCT07580092
Karolinska InstitutetAnkylosing Spondylitis, Inflammatory Joint Disease (IJD), Polyarthritis +2
Start: 2023-11-30End: 2026-03-05Updated: 2026-05-12

Related Papers

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema
Journal of Clinical Medicine2020-07-1411 citations